BRD4 and hepatocellular carcinoma: Therefore, we suggested that BRD4/8/9 were promising candidate biomarkers in HCC, although over-expression of BRD4 had no significant correlation with shorter OS in the GEPIA database and BRD4/9 were not independent predictors of OS in HCC patients.